Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2000

View Archived Issues

Alkermes and Glaxo Wellcome finalize pulmonary drug delivery agreement

Antex traveler's diarrhea vaccine awarded funding from U.S Army

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

BTG obtains rights for a novel approach to treat malaria

Genzyme General and Genzyme Tissue Repair extend NeuroCell-PD milestone deadline

BioChem Pharma sells share of North American Vaccine

Aviron initiates clinical testing of CMV vaccine

Positive preliminary phase I/II results of HCT-1026 in contact urticaria

Argatroban approved for HIT in U.S.

Systemically administered caspase inhibitor provides neuroprotection in rat model

Aventis and NPS Allelix join together to develop novel, selective dopamine D4 antagonists

Novel NK1 receptor antagonists: synthesis and SAR presented by Merck in Kansas City

New human prolactin receptor antagonist S179D-PRL undergoes extensive biological testing

NC-2100: a new thiazolidinedione with a unique pharmacological profile

Organon's Orgalutran approved in E.U. for treatment of infertility

Elaidic acid ester of ganciclovir as a promising new Rx for herpesvirus infections

Prolifix enters agreement for cell cycle protein research

Synthetic conjugated oral estrogen holds significant promise as HRT for postmenopausal women

Agenerase receives positive opinion from CPMP

Topiramate now claimed effective in schizophrenia

Ferrer's new antihypertensive angiotensin II antagonists prove more potent than losartan

Dual estrogen agonist/antagonist compounds and their use revealed by Akzo Nobel

Potent HCV NS3 protease inhibitors designed at Italian laboratory

Potential new treatments for asthma from Roche act as chemokine receptor antagonists

Peptides useful in toxic shock syndrome discovered by Rockefeller U. researchers

Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes

Patent issued to Meiji Seika covering benzoxazole derivatives and use for treating GI disorders

Naphthalene compounds from Torii promote fibrinolysis and exert antithrombotic activity

Biomira acquires remaining rights to Theratope from Chiron

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...